Relmacabtagene Autoleucel
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Relmacabtagene Autoleucel, covering 2023-06-15 to 2026-01-21. Get the full timeline:
Most recent: Clinical Trial Update: Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma [Phase 2]